Şunu aradınız:: jitqaxxar (Maltaca - İngilizce)

jitqaxxar mill-qoxra tiegħu,
be stripped of its bark,

aqla’ s-siġill li jitqaxxar.
pull off the peeloff seal.

neħħi s-siġill li jitqaxxar.
remove the peel-off seal.

qartas li jista ’ jitqaxxar f’ kaxxa tal- kartun:
peel off sachet in a cardboard carton:

il-backing foil għandu jitqaxxar u l-kapsula tista’ titneħħa.
the backing foil should be peeled off and the capsule can be removed.

jekk is-siġill li jitqaxxar ikollu xi ħsara jew ikun maħlul, tużax il-labra.
if the peel-off seal is damaged or loose, do not use the needle.

xi ftit mis-saff ta’ barra tal-ġilda tiegħek jista’ jitqaxxar (erożjoni)
some of the outer layer of your skin may wear away (erosion)

jekk is-siġill li jitqaxxar ikun bil-ħsara jew ikun maħlul, tużax il-labra u ħu waħda ġdida.
if the peeloff seal is damaged or loose, do not use the needle and get another one.

iċċekkja li s-siġill li jitqaxxar fuq l-għatu ta’ barra tal-labra ma jkollux ħsara jew ikun maħlul.
check that the peeloff seal on the outer needle cap is not damaged or loose.

iċċekkja li s-siġill li jitqaxxar fuq l-għatu ta’ barra tal-labra ma jkollux xi ħsara jew ikun maħlul:
check that the peel-off seal on the outer needle cap is not damaged or loose:

sepsis* (ta’ spiss imsejħa “avvelenament tad-demm”, hi infezzjoni severa b’rispons infjammatorju tal- ġisem kollu), nefħa mgħaġġla tal-ġilda u l-mukuża (anġjoedema), jitilgħu l-infafet u s-saff ta’ fuq tal- ġilda jitqaxxar (nekrolisi epidermali tossika); dawn l-effetti sekondarji huma rari (jistgħu jaffettwaw sa persuna 1 minn kull 1,000) jew ta’ frekwenza mhux magħrufa (nekrolisi epidermali tossika) iżda huma estremament serji u l-pazjenti għandhom jieqfu jieħdu l-mediċina u jaraw lit-tabib tagħhom immedjatament.
sepsis* (often called "blood poisoning"), is a severe infection with whole-body inflammatory response, rapid swelling of the skin and mucosa (angioedema), blistering and peeling of the top layer of skin (toxic epidermal necrolysis); these side effects are rare (may affect up to 1 in 1,000 people) or of unknown frequency (toxic epidermal necrolysis) but are extremely serious and patients should stop taking the medicine and see their doctor immediately.